VANGUARD GROUP INC - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 27 filers reported holding GLYCOMIMETICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q3 2023$3,632,804
-9.8%
2,421,869
+4.6%
0.00%
Q2 2023$4,027,065
+29.9%
2,314,405
-6.0%
0.00%
Q1 2023$3,100,649
-55.0%
2,460,833
+8.1%
0.00%
Q4 2022$6,895,410
+564.9%
2,275,713
+21.1%
0.00%
Q3 2022$1,037,000
-6.2%
1,879,412
+1.8%
0.00%
Q2 2022$1,105,000
-46.6%
1,846,762
+1.8%
0.00%
Q1 2022$2,069,000
-35.8%
1,814,963
-18.9%
0.00%
Q4 2021$3,224,000
-34.9%
2,238,553
-0.9%
0.00%
Q3 2021$4,949,000
-6.1%
2,260,014
-0.5%
0.00%
Q2 2021$5,268,000
-34.2%
2,270,457
-14.6%
0.00%
Q1 2021$8,001,000
-17.2%
2,658,133
+3.5%
0.00%
Q4 2020$9,660,000
+79.3%
2,569,239
+46.4%
0.00%
Q3 2020$5,387,000
-12.8%
1,754,616
+6.8%
0.00%
Q2 2020$6,175,000
+54.9%
1,642,222
-6.1%
0.00%
Q1 2020$3,987,000
-56.8%
1,748,251
+0.2%
0.00%
Q4 2019$9,231,000
+22.3%
1,745,054
-0.3%
0.00%
Q3 2019$7,546,000
-63.6%
1,750,903
+0.7%
0.00%
-100.0%
Q2 2019$20,734,000
-9.4%
1,739,398
-5.3%
0.00%0.0%
Q1 2019$22,874,000
+32.3%
1,835,777
+0.5%
0.00%0.0%
Q4 2018$17,293,000
-29.0%
1,826,027
+7.9%
0.00%0.0%
Q3 2018$24,358,000
-9.3%
1,691,550
+1.6%
0.00%0.0%
Q2 2018$26,850,000
+9.0%
1,664,599
+9.7%
0.00%0.0%
Q1 2018$24,632,000
+42.0%
1,517,700
+46.9%
0.00%0.0%
Q4 2017$17,341,000
+34.2%
1,032,836
+11.9%
0.00%0.0%
Q3 2017$12,917,000
+37.1%
923,244
+9.4%
0.00%
Q2 2017$9,421,000
+299.4%
844,190
+94.3%
0.00%
Q1 2017$2,359,000
-8.9%
434,501
+2.4%
0.00%
Q4 2016$2,589,000
-11.5%
424,444
+3.7%
0.00%
Q3 2016$2,927,000
+2.5%
409,430
+4.2%
0.00%
Q2 2016$2,857,000
+104.4%
392,892
+67.5%
0.00%
Q1 2016$1,398,000
+12.7%
234,570
+8.1%
0.00%
Q4 2015$1,241,000
-99.1%
217,002
-95.4%
0.00%
-100.0%
Q3 2015$139,420,000
+8308.9%
4,678,934
+2144.1%
0.01%
Q2 2015$1,658,000
-4.2%
208,502
+0.3%
0.00%
Q1 2015$1,730,000
+17.5%
207,889
+1.6%
0.00%
Q4 2014$1,472,000
+4.4%
204,565
+0.7%
0.00%
Q3 2014$1,410,000
+13.5%
203,165
+37.9%
0.00%
Q2 2014$1,242,000
-39.5%
147,335
+17.1%
0.00%
Q1 2014$2,054,000125,8000.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
BVF INC/IL 7,361,801$31,729,0003.33%
NEA Management Company, LLC 9,089,041$39,174,0003.24%
Camber Capital Management LP 3,500,000$15,085,0000.79%
Redmile Group, LLC 1,997,647$8,610,0000.29%
Alambic Investment Management, L.P. 41,698$180,0000.14%
CAXTON CORP 26,575$115,0000.13%
PRENTISS SMITH & CO INC 17,000$73,0000.05%
Virtus ETF Advisers LLC 22,580$97,0000.02%
AXA S.A. 1,825,738$7,868,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 30,000$129,0000.01%
View complete list of GLYCOMIMETICS INC shareholders